U.S. deaths from covid-19 passed 60,000 on Wednesday, a figure President Trump had once projected would be the upper limit, as hopes rose for a drug treatment that the top U.S. infectious-disease expert said has shown a clear benefit in an early trial.

Trump welcomed the promising early signs that an experimental antiviral drug, remdesivir, can be effective in speeding the recovery time for covid-19 patients.

“The data shows that remdesivir has a clear-cut, significant, positive effect in diminishing the time to recovery,” Anthony S. Fauci said alongside Trump at the White House on Wednesday. “That is really quite important.”

The National Institute of Allergy and Infectious Diseases, which Fauci leads, is overseeing a study of more than 1,000 patients in the United States and around the world….

Read the full The Washington Post article